Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
Phase 3
Completed
- Conditions
- Kidney Transplantation
- Registration Number
- NCT00099801
- Lead Sponsor
- Novartis Pharmaceuticals
- Brief Summary
The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Patients undergoing their first kidney transplant
- Male or female age 18 to 65 years
Exclusion Criteria
- Patients in need of second kidney transplant or multi-organ transplants.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method